[HTML] nature.comFull View

[HTML][HTML] The oncology biomarker discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

AJ Ohnmacht, A Stahler, S Stintzing, DP Modest… - Nature …, 2023 - nature.com
Precision medicine has revolutionised cancer treatments; however, actionable biomarkers
remain scarce. To address this, we develop the Oncology Biomarker Discovery (OncoBird) …
被引用次数：5 相关文章

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

AJ Ohnmacht, A Stahler, S Stintzing… - Nature …, 2023 - ui.adsabs.harvard.edu
Precision medicine has revolutionised cancer treatments; however, actionable biomarkers
remain scarce. To address this, we develop the Oncology Biomarker Discovery (OncoBird) …
[HTML] nih.gov

[HTML][HTML] The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

AJ Ohnmacht, A Stahler, S Stintzing… - Nature …, 2023 - ncbi.nlm.nih.gov
Precision medicine has revolutionised cancer treatments; however, actionable biomarkers
remain scarce. To address this, we develop the Oncology Biomarker Discovery (OncoBird) …

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer.

AJ Ohnmacht, A Stahler, S Stintzing… - Nature …, 2023 - search.ebscohost.com
Precision medicine has revolutionised cancer treatments; however, actionable biomarkers
remain scarce. To address this, we develop the Oncology Biomarker Discovery (OncoBird) …

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

AJ Ohnmacht, A Stahler, S Stintzing… - Nature …, 2023 - econpapers.repec.org
Precision medicine has revolutionised cancer treatments; however, actionable biomarkers
remain scarce. To address this, we develop the Oncology Biomarker Discovery (OncoBird) …

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

AJ Ohnmacht, A Stahler, S Stintzing… - Nature …, 2023 - ideas.repec.org
Precision medicine has revolutionised cancer treatments; however, actionable biomarkers
remain scarce. To address this, we develop the Oncology Biomarker Discovery (OncoBird) …

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer.

AJ Ohnmacht, A Stahler, S Stintzing… - Nature …, 2023 - europepmc.org
Precision medicine has revolutionised cancer treatments; however, actionable biomarkers
remain scarce. To address this, we develop the Oncology Biomarker Discovery (OncoBird) …

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer

AJ Ohnmacht, A Stahler, S Stintzing… - Nature …, 2023 - pubmed.ncbi.nlm.nih.gov
Precision medicine has revolutionised cancer treatments; however, actionable biomarkers
remain scarce. To address this, we develop the Oncology Biomarker Discovery (OncoBird) …

The Oncology Biomarker Discovery framework reveals cetuximab and bevacizumab response patterns in metastatic colorectal cancer.

AJ Ohnmacht, A Stahler, S Stintzing… - Nature …, 2023 - europepmc.org
Precision medicine has revolutionised cancer treatments; however, actionable biomarkers
remain scarce. To address this, we develop the Oncology Biomarker Discovery (OncoBird) …